Home
Contact Palatin
Site Map
.
.
.
.
.
.
Overview
Press Releases
Presentations
Events Calendar
Webcasts
Media Kit
Corporate Fact Sheet
Bremelanotide Fact Sheet
MIDAS™ Fact Sheet
Melanocortin Fact Sheet
Press Releases
2002
2003
2004
2005
all
Displaying releases:
1-15
|
16-30
|
31-45
|
46-60
|
61-75
|
76-90
|
91-105
|
106-120
|
121-135
|
136-150
|
151-165
|
166-180
|
181-195
|
196-203
Jan-22-2008
Palatin Technologies Announces Litigation Settlement With Competitive Technologies
Nov-09-2007
Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be held on November 9, 2007
Nov-05-2007
Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007
Nov-02-2007
Palatin Technologies to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Oct-31-2007
Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
Sep-27-2007
Palatin Technologies, Inc. Reports Positive Data from an At-home Study of Pre- and Postmenopausal Women with Female Sexual Arousal Disorder Treated with Bremelanotide
Sep-26-2007
Palatin Technologies Announces Reduction of Workforce
Sep-14-2007
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Sep-13-2007
Palatin Technologies To Report Fourth Quarter And Fiscal Year End 2007 Financial Results; Conference Call And Webcast On September 18, 2007
Sep-12-2007
Palatin Technologies Refutes Competitive Technologies Contention Of Material Breach
Sep-10-2007
Palatin Technologies Announces Reacquisition Of Full Rights To Bremelanotide Program
Aug-30-2007
King Pharmaceuticals And Palatin Technologies Delay Immediate Plans For Phase 3 Clinical Program With Bremelanotide For Erectile Dysfunction
Jun-25-2007
King Pharmaceuticals and Palatin Technologies Announce End-of-Phase 2 Meeting with FDA for Bremelanotide
May-22-2007
Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
May-11-2007
Palatin Technologies To Present At The Acumen BioFin 4th Annual Global Healthcare Conference
Overview
Press Releases
Event Calendar
Webcasts
SEC Filings
Analyst Coverage
Corporate Governance
Information Request
E-Mail Alerts
Investor Materials
Overview
Executive Management
Board of Directors
Overview
Employee Benefits
Career Opportunities
Overview
Press Releases
Presentations
Events Calendar
Webcasts
Media Kit
Overview
PL-3994 for CHF
PL-3994 for Asthma
PL-3994 for Hypertension
Bremelanotide
PL-6983
Obesity